Published in J Virol on September 01, 1993
A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J Virol (1994) 1.64
Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes. J Virol (1995) 1.11
Residues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions. J Virol (2005) 1.09
Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions. J Virol (1994) 0.85
A small region of the ecotropic murine leukemia virus (MuLV) gag gene profoundly influences the types of polytropic MuLVs generated in mice. J Virol (1997) 0.83
Mapping of a major osteomagenic determinant of murine leukemia virus RFB-14 to non-long terminal repeat sequences. J Virol (1997) 0.80
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci U S A (1977) 13.96
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J Virol (1981) 13.11
Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc Natl Acad Sci U S A (1980) 6.73
A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A (1975) 5.91
The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol (1992) 5.30
Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J Virol (1985) 5.21
Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus. J Virol (1980) 4.91
Role for the 3' end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc Natl Acad Sci U S A (1983) 4.68
Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens. Virology (1981) 3.61
Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sci U S A (1991) 3.18
A 3' end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus. J Virol (1984) 3.16
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol (1990) 3.00
Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev (1990) 2.75
Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell (1986) 2.69
The role of branchpoint and 3'-exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev (1991) 2.58
Role of intron-contained sequences in formation of moloney murine leukemia virus env mRNA. Mol Cell Biol (1984) 2.21
At least four viral genes contribute to the leukemogenicity of murine retrovirus MCF 247 in AKR mice. J Virol (1985) 2.20
Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J Mol Biol (1992) 1.89
Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene. Proc Natl Acad Sci U S A (1989) 1.85
Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing. Virology (1991) 1.84
A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc Natl Acad Sci U S A (1992) 1.83
Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic retrovirus. J Virol (1984) 1.82
Intronic sequences and 3' splice sites control Rous sarcoma virus RNA splicing. J Virol (1992) 1.79
A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus. EMBO J (1986) 1.75
Effect of murine host genotype on MCF virus expression, latency, and leukemia cell type of leukemias induced by Friend murine leukemia helper virus. Virology (1983) 1.62
Emergence of tumorigenic cells during the course of Friend virus leukemias. Proc Natl Acad Sci U S A (1981) 1.52
A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers. J Virol (1988) 1.40
Substitution of leucine for isoleucine in a sequence highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the Friend murine leukemia virus. Proc Natl Acad Sci U S A (1991) 1.40
Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses. J Virol (1990) 1.34
Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis. J Virol (1990) 1.32
Transfection of DNA into adherent cells by DEAE-dextran/DMSO method increases drastically if the cells are removed from surface and treated in suspension. Nucleic Acids Res (1989) 1.27
The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease. J Virol (1991) 1.17
Contribution of the gag and pol sequences to the leukemogenicity of Friend murine leukemia virus. J Virol (1985) 1.13
Murine retrovirus-induced spongiform encephalomyelopathy: host and viral factors which determine the length of the incubation period. J Virol (1992) 1.12
The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain. J Virol (1992) 0.88
HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect. Virology (1992) 0.85
Roots of clinical resistance to STI-571 cancer therapy. Science (2001) 9.78
Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell (1986) 2.69
Local and remote sustained trigger point therapy for exacerbations of chronic low back pain. A randomized, double-blind, controlled, multicenter trial. Spine (Phila Pa 1976) (1997) 2.29
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect (2009) 2.13
A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J Virol (1998) 1.89
A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J Virol (1994) 1.64
Systemic adverse effect of antithyroid drugs. Clin Rheumatol (1999) 1.50
[Neuro-reflexotherapy intervention in the treatment of non specified low back pain: a randomized, controlled, double-blind clinical trial]. Med Clin (Barc) (1993) 1.46
A national prevalence study of pressure ulcers in French hospital inpatients. J Wound Care (2008) 1.44
Liquid pasteurization of an immunoglobulin preparation without stabilizer: effects on its biological and biochemical properties. Vox Sang (1996) 1.42
Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatr (2010) 1.42
Substitution of leucine for isoleucine in a sequence highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the Friend murine leukemia virus. Proc Natl Acad Sci U S A (1991) 1.40
Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain. Emerg Infect Dis (1996) 1.39
Effectiveness of the 2010/11 seasonal trivalent influenza vaccine in Spain: preliminary results of a case-control study. Euro Surveill (2011) 1.34
Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses. J Virol (1990) 1.34
Human case of swine influenza A (H1N1), Aragon, Spain, November 2008. Euro Surveill (2009) 1.26
Pseudotyping of dual-tropic recombinant viruses generated by infection of mice with different ecotropic murine leukemia viruses. Virology (1985) 1.25
Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill (2013) 1.22
Conserved framework of envelope glycoproteins among lentiviruses. Curr Top Microbiol Immunol (1994) 1.15
Role of emerging respiratory viruses in children with severe acute wheezing. Pediatr Pulmonol (2010) 1.15
Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am J Physiol (1997) 1.14
Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus. J Biol Chem (2000) 1.12
Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes. J Virol (1995) 1.11
From contraception to cancer: a review of the therapeutic applications of LHRH analogues as antitumor agents. Yale J Biol Med (1982) 1.06
Genetic control of sensitivity to Moloney-virus-induced leukemias in mice. I. Demonstration of multigenic control. Int J Cancer (1978) 1.06
Viral infections of the central nervous system in Spain: a prospective study. J Med Virol (2012) 1.04
Ihibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone. Endocr Res Commun (1975) 1.03
TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J Virol (1996) 1.02
Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses. J Virol (1993) 0.98
A novel subgenomic murine leukemia virus RNA transcript results from alternative splicing. J Virol (2000) 0.98
Determinants of patient delay among tuberculosis cases in Spain. Eur J Public Health (2004) 0.97
p95vav associates with the nuclear protein Ku-70. Mol Cell Biol (1996) 0.96
Functional tolerance of the human immunodeficiency virus type 1 envelope signal peptide to mutations in the amino-terminal and hydrophobic regions. J Virol (1992) 0.96
Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties. J Virol (1999) 0.95
Determinants of health system delay among confirmed tuberculosis cases in Spain. Eur J Public Health (2005) 0.95
Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill (2012) 0.93
Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveill (2014) 0.93
Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine (2012) 0.92
Genetic control of sensitivity to Moloney leukemia virus in mice. II. Mapping of three resistant genes within the H-2 complex. J Immunol (1979) 0.91
Measurement of pleural pressure during therapeutic thoracentesis. Am J Respir Crit Care Med (2000) 0.89
Atrial natriuretic factor stimulates testosterone production by mouse interstitial cells. Eur J Pharmacol (1985) 0.88
Pituitary and plasma LH of ovariectomized rats with median eminence implants of LH. Endocrinology (1966) 0.88
Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia. Am J Respir Crit Care Med (1998) 0.87
The anti-reproductive pharmacology of LH-RH and agonistic analogues. Int J Fertil (1978) 0.86
Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions. J Virol (1994) 0.85
Friend murine leukaemia virus is integrated at a common site in most primary spleen tumours of erythroleukaemic animals. Oncogene (1992) 0.85
Tuberculosis in Spain: epidemiological pattern and clinical practice. Int J Tuberc Lung Dis (2002) 0.85
Viral diagnosis of neurological infection by RT multiplex PCR: a search for entero- and herpesviruses in a prospective study. J Med Virol (1999) 0.84
Formation of asteroid pairs by rotational fission. Nature (2010) 0.84
Monoclonal proliferation of Friend murine leukemia virus-transformed myeloblastic cells occurs early in the leukemogenic process. Mol Cell Biol (1985) 0.83
Human-enteric-coronaviruslike particles (CVLP) with different epidemiological characteristics. J Med Virol (1985) 0.83
Resistance of the mouse to the antifertility effects of LHRH agonists. Life Sci (1982) 0.83
The CIBERES Pulmonary Biobank Consortium: an opportunity for cooperative international respiratory research. Eur Respir J (2011) 0.82
"Internal" feedback mechanism: response of pituitary FSH and of stalk-median eminence follicle stimulating hormone-releasing factor to median eminence implants of FSH. Endocrinology (1967) 0.82
Effect of median eminence implants of LH on pituitary LH of female rats. Endocrinology (1966) 0.81
Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells. Leukemia (2005) 0.81
Altered transcription of genes coding for class I histocompatibility antigens in murine tumor cells. J Exp Med (1983) 0.80
Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill (2014) 0.80
Blood pressure changes after gastric mechanical and electrical stimulation in rats. Am J Physiol (1985) 0.80
Sequences in the rev-responsive element responsible for premature translational arrest in the human-immunodeficiency-virus-type-1 envelope. Eur J Biochem (1993) 0.79
Canine large granular lymphocyte leukemia and its derived cell line produce infectious retroviral particles. Vet Pathol (2000) 0.79
Luteinizing hormone releasing hormone agonists induce ovulation in hypophysectomized proestrous rats: direct ovarian effect. Life Sci (1981) 0.79
Luteinizing hormone-releasing hormone. Antiovulatory activity of analogs substituted in positions 2 and 6. J Med Chem (1975) 0.79
The differential effects of diestrous progestogen administration of proestrous gonadotrophin levels. Endocrinology (1975) 0.79
Human bocavirus infection in a neonatal intensive care unit. J Infect (2008) 0.79
Rotavirus prevalence and relationships with climatological factors in Gabon, Africa. J Med Virol (1985) 0.79
First influenza season after the 2009 pandemic influenza: report of the first 300 ICU admissions in Spain. Med Intensiva (2011) 0.79
Pre-and postcoital contraceptive activity of LH-RH in the rat. Biol Reprod (1977) 0.79
Post-coital contraceptive and uterotrophic effects of luteinizing hormone releasing hormone. Endocr Res Commun (1975) 0.79
Evidence for the internal feedback phenomenon in human subjects: effects of ACTH on plasma CRF. Acta Endocrinol (Copenh) (1973) 0.78
HLA-B27, a dominant restricting element in antiviral responses? Immunogenetics (1984) 0.78
Aminopyrimidines with high affinity for both serotonin and dopamine receptors. J Med Chem (1998) 0.78
Pituitary-hypothalamic dysfunction in generalized lipodystrophy. J Pediatr (1973) 0.78
Effect of synthetic luteinizing hormone releasing hormone on pituitary and serum levels of luteinizing hormone of intact and median eminence lesioned male rats. Experientia (1973) 0.78
Mechanism of the postcoital contraceptive effect of LH-RH in the rat. I. Serum hormone levels during chronic LH-RH Administration. Biol Reprod (1977) 0.78
Hypothalamic control of pituitary follicle-stimulating hormone synthesis. Endocrinology (1971) 0.78
Aortitis: a new manifestation of primary antiphospholipid syndrome. Br J Rheumatol (1995) 0.77
Baboon Endogenous C type Virus induces syncytium formation in Epstein barr virus (EBV) carrying lymphoblastoid human cell lines. Arch Virol (1983) 0.77
Prevalence of non-T-cells in the replication of the N-tropic, type C virus of young AKR mice. Cancer Res (1978) 0.77
An "internal" feedback mechanism controlling follicle stimulating hormone releasing factor. Endocrinology (1970) 0.77
The relevance of the pharmacologic properties of a progestational agent to its clinical effects as a combination oral contraceptive. Yale J Biol Med (1990) 0.77
Suboptimal and optimal activation signals modulate differently the expression of HIV-1 and cytokine genes. Biochem Biophys Res Commun (1992) 0.77
Growth hormone reduces bacterial translocation in radiation enteritis in the rat. Rev Esp Enferm Dig (1998) 0.77
Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data. Euro Surveill (2015) 0.77
Intestinal involvement in Sweet's syndrome. J Am Acad Dermatol (1996) 0.76
The envelopes of two ecotropic murine leukemia viruses display distinct efficiencies in retroviral vaccination by interference. Virology (1994) 0.76
[Etiology of acute infantile gastroenteritis in Gabon]. Bull Soc Pathol Exot Filiales (1985) 0.76
Pharmacodynamic analysis of a serine protease inhibitor, MK-4519, against hepatitis C virus using a novel in vitro pharmacodynamic system. Antimicrob Agents Chemother (2011) 0.76
[Autoimmune diabetes after treatment with interferon-alpha]. Presse Med (1995) 0.75
Anti-influenza human T killer cells present an intertypic activity anti-A and -B type viruses in a secondary reaction in vitro. Clin Exp Immunol (1983) 0.75
Characterization of a canine long-term T cell line (DLC 01) established from a dog with Sézary syndrome and producing retroviral particles. Leukemia (1999) 0.75
Hypothesis: hypothalamic dysfunction and lipoatrophic diabetes. Yale J Biol Med (1973) 0.75
[Intra-abdominal desmoid tumor]. Cir Esp (2005) 0.75